Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in ANIK — Anika Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in ANIK

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$329,672
-$245,784 QoQ
Shares Held
22,736
-62.0% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. ANIK ranks #14 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIK

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $329,672 22,736
2025-12-31 $575,456 59,881
2025-09-30 $431,817 45,938
2025-06-30 $454,876 42,994
2025-03-31 $517,347 34,421
2024-12-31 $681,526 41,405
2024-09-30 $1,422,868 57,606
2024-06-30 $1,489,859 58,818
2024-03-31 $1,526,133 60,084
2023-12-31 $1,192,867 52,642
2023-09-30 $971,181 52,130
2023-06-30 $1,211,317 46,625
2023-03-31 $459,462 15,998